Majewski Osteodysplastic Primordial Dwarfism Type II (MOPD II): Expanding the vascular phenotype
- 26 March 2010
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 152A (4) , 960-965
Abstract
Majewski Osteodysplastic Primordial Dwarfism, Type II (MOPD II) is a rare, autosomal recessive disorder. Features include severe intrauterine growth retardation (IUGR), poor postnatal growth (adult stature approximately 100 cm), severe microcephaly, skeletal dysplasia, characteristic facial features, and normal or near normal intelligence. An Institutional Review Board (IRB) approved registry was created and currently follows 25 patients with a diagnosis of MOPD II. Based on previous studies, a neurovascular screening program was implemented and 13 (52%) of these patients have been found to have cerebral neurovascular abnormalities including moyamoya angiopathy and/or intracranial aneurysms. The typical moyamoya pathogenesis begins with vessel narrowing in the supraclinoid internal carotid artery, anterior cerebral (A1) or middle cerebral (M1) artery segments. The narrowing may predominate initially on one side, progresses to bilateral stenosis, with subsequent occlusion of the vessels and collateral formation. We present four patients who, on neurovascular screening, were found to have cerebrovascular changes. Two were asymptomatic, one presented with a severe headache and projectile vomiting related to a ruptured aneurysm, and one presented after an apparent decline in cognitive functioning. Analysis of the registry suggests screening for moyamoya disease be performed at the time of MOPD II diagnosis and at least every 12–18 months using MRA or computerized tomographic angiography (CTA). We believe this is imperative. If diagnosed early enough, re‐vascularization and aneurysm treatment in skilled hands can be performed safely and prevent or minimize long‐term sequelae in this population. Emergent evaluation is also needed when other neurologic or cardiac symptoms are present.Keywords
This publication has 13 references indexed in Scilit:
- Pathophysiology and genetic factors in moyamoya diseaseNeurosurgical Focus, 2009
- Moyamoya Disease and Moyamoya SyndromeNew England Journal of Medicine, 2009
- Mutations in the Pericentrin ( PCNT ) Gene Cause Primordial DwarfismScience, 2008
- Cardiac Troponin-I: A Predictor of Prognosis in Subarachnoid HemorrhageNeurocritical Care, 2007
- Majewski osteodysplastic primordial dwarfism type II (MOPD II) complicated by stroke: Clinical report and review of cerebral vascular anomaliesAmerican Journal of Medical Genetics Part A, 2005
- Cardiac Troponin Elevation, Cardiovascular Morbidity, and Outcome After Subarachnoid HemorrhageCirculation, 2005
- Majewski osteodysplastic primordial dwarfism type II (MOPD II): Natural history and clinical findingsAmerican Journal of Medical Genetics Part A, 2004
- Congenital fibromuscular dysplasia involving multivessels in an infant with fatal outcomeEuropean Journal of Pediatrics, 2004
- Asymptomatic Moyamoya Disease Associated With Coronary and Renal Artery StenosesJapanese Circulation Journal, 1998
- Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: Neurogenic stunned myocardiumJACC, 1994